HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAB5. A total of 11 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,978,125 | +39.6% | 2,500,000 | 0.0% | 0.16% | +33.1% |
| Q3 2022 | $4,282,000 | -8.7% | 2,500,000 | 0.0% | 0.12% | -4.7% |
| Q2 2022 | $4,692,000 | +7.2% | 2,500,000 | 0.0% | 0.13% | +25.7% |
| Q1 2022 | $4,376,000 | +24.2% | 2,500,000 | +25.0% | 0.10% | +42.3% |
| Q4 2021 | $3,522,000 | -1.0% | 2,000,000 | 0.0% | 0.07% | -9.0% |
| Q3 2021 | $3,557,000 | -9.1% | 2,000,000 | 0.0% | 0.08% | -11.4% |
| Q2 2021 | $3,915,000 | +6.5% | 2,000,000 | 0.0% | 0.09% | +2.3% |
| Q1 2021 | $3,676,000 | – | 2,000,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | 33,248,000 | $62,594,000 | 0.63% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 12,750,000 | $24,079,000 | 0.54% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,500,000 | $4,692,000 | 0.13% |
| Calamos Advisors LLC | 10,000,000 | $18,996,000 | 0.08% |
| Hudson Bay Capital Management LP | 4,000,000 | $7,530,000 | 0.06% |
| D. E. Shaw & Co., Inc. | 17,444,000 | $32,805,000 | 0.04% |
| BNP PARIBAS FINANCIAL MARKETS | 3,867,000 | $7,345,799,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 1,055,000 | $2,004,000 | 0.00% |
| JPMORGAN CHASE & CO | 2,816,000 | $5,200,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,843,000 | $3,455,000 | 0.00% |